Pentasa: profile and news

Shire Announces Good Start to the Year and Guidance Reaffirmed  Apr 27, 2006
...parties referred to in this press issue: 3TC (trademark of GlaxoSmithKline (GSK)) DYNEPO (trademark of Aventis Pharma Holdings GmbH) PENTASA (trademark of ... - PR Newswire (press release),

Ferring integrates its operations  May 3, 2006
Pentasa (mesalazine) for example, for the treatment of inflammatory bowel diseases (IBD), which is currently made in Denmark, will undergo closed process at ... - In-PharmaTechnologist.com,

Shire Announces Good Start to the Year and Guidance Reaffirmed  Apr 27, 2006
Sales Sales US Rx US Market US$M Growth (2) Growth (1) (2) Share (1) Product ADDERALL XR 206.1 +42% +10% 26% CARBATROL 14.1 -17% -13% 42% PENTASA 28.1 +7% -1 ... - Yahoo! News (press release)

Shire Announces Good Start to the Year and Guidance Reaffirmed  Apr 27, 2006
PENTASA had a 17% share of the total US oral mesalamine prescription market in March 2006 (March 2005: 18%), a market that grew 4% compared with the same ... - PR Newswire UK (press release),